Public Sector Pension Investment Board (PSP Investments)
EGRX

Public Sector Pension Investment Board (PSP Investments)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Public Sector Pension Investment Board (PSP Investments)’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-18,314
Closed -$520K – 1419
2023
Q1 		$520K Sell
18,314
-630
-3% -$18.7K ﹤0.01% 1351
2022
Q4 		$554K Sell
18,944
-537
-3% -$17.1K ﹤0.01% 1354
2022
Q3 		$515K Sell
19,481
-1,206
-6% -$44.3K ﹤0.01% 1311
2022
Q2 		$919K Sell
20,687
-584
-3% -$26.8K 0.01% 1194
2022
Q1 		$1.05M Sell
21,271
-1,880
-8% -$90.2K 0.01% 1256
2021
Q4 		$1.18M Sell
23,151
-140
-0.6% -$7.25K 0.01% 1275
2021
Q3 		$1.3M Sell
23,291
-2,632
-10% -$130K 0.01% 1267
2021
Q2 		$1.11M Sell
25,923
-3,575
-12% -$148K 0.01% 1305
2021
Q1 		$1.23M Buy
29,498
+3,837
+15% +$178K 0.01% 1208
2020
Q4 		$1.2M Sell
25,661
-1,150
-4% -$53.8K 0.01% 1106
2020
Q3 		$1.14M Buy
26,811
+4,180
+18% +$183K 0.01% 1140
2020
Q2 		$1.09M Hold
22,631
– – 0.01% 1076
2020
Q1 		$1.04M Hold
22,631
– – 0.01% 944
2019
Q4 		$1.36M Sell
22,631
-3,000
-12% -$179K 0.01% 1270
2019
Q3 		$1.45M Buy
25,631
+2,940
+13% +$165K 0.01% 1184
2019
Q2 		$1.26M Buy
22,691
+12,900
+132% +$673K 0.01% 1194
2019
Q1 		$494K Hold
9,791
– – ﹤0.01% 1339
2018
Q4 		$394K Buy
9,791
+2,100
+27% +$108K ﹤0.01% 1398
2018
Q3 		$533K Buy
7,691
+2,573
+50% +$195K ﹤0.01% 1277
2018
Q2 		$387K Hold
5,118
– – ﹤0.01% 1270
2018
Q1 		$270K Hold
5,118
– – ﹤0.01% 1309
2017
Q4 		$273K Hold
5,118
– – ﹤0.01% 1358
2017
Q3 		$305K Buy
5,118
+918
+22% +$55.5K ﹤0.01% 1293
2017
Q2 		$331K Sell
4,200
-1,400
-25% -$114K ﹤0.01% 1148
2017
Q1 		$464K Hold
5,600
– – ﹤0.01% 1120
2016
Q4 		$444K Hold
5,600
– – ﹤0.01% 1133
2016
Q3 		$392K Buy
+5,600
New +$310K ﹤0.01% 1115

Other funds holding EGRX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments)'s EGRX Position: Q2 2023 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of Eagle Pharmaceuticals, Inc. (EGRX) in Q2 2023, closing a stake of 18,314 shares — an estimated $520K sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in EGRX in Q3 2016 and held it in 27 quarters. The position peaked at $1.45M in Q3 2019. 126 funds tracked by Wall St. Rank hold EGRX as of Q2 2023.

  • Public Sector Pension Investment Board (PSP Investments) reported no remaining Eagle Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
  • Public Sector Pension Investment Board (PSP Investments) sold 18,314 Eagle Pharmaceuticals, Inc. shares in Q2 2023, an estimated $520K.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Eagle Pharmaceuticals, Inc. in Q3 2016 and held it in 27 quarters.
  • Public Sector Pension Investment Board (PSP Investments)'s Eagle Pharmaceuticals, Inc. position peaked at $1.45M in Q3 2019.
  • 126 funds tracked by Wall St. Rank held Eagle Pharmaceuticals, Inc. as of Q2 2023.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q2 2023, filed 14 Aug 2023.